Cargando…

Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication Study

BACKGROUND: The serotonin transporter gene (SLC6A4; 5-HTT; SERT) is considered a prime candidate in pharmacogenetic research in major depressive disorder (MDD). Besides genetic variation, recent advances have spotlighted the involvement of epigenetic mechanisms such as DNA methylation in predicting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schiele, M A, Zwanzger, P, Schwarte, K, Arolt, V, Baune, B T, Domschke, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968622/ https://www.ncbi.nlm.nih.gov/pubmed/33125470 http://dx.doi.org/10.1093/ijnp/pyaa081

Ejemplares similares

Therapeutic Antidepressant Potential of NONHSAG045500 in Regulating Serotonin Transporter in Major Depressive Disorder
por: Liu, Song, et al.
Publicado: (2018)

DNA hypomethylation of the Krüppel-like factor 11 (KLF11) gene promoter: a putative biomarker of depression comorbidity in panic disorder and of non-anxious depression?
por: Kollert, Leonie, et al.
Publicado: (2020)

Magnetoencephalographic Correlates of Emotional Processing in Major Depression Before and After Pharmacological Treatment
por: Domschke, Katharina, et al.
Publicado: (2015)

A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder
por: Baune, Bernhard T, et al.
Publicado: (2017)

Monoamine Oxidase A Hypomethylation in Obsessive-Compulsive Disorder: Reversibility By Successful Psychotherapy?
por: Schiele, Miriam A, et al.
Publicado: (2020)

KPNA3 Variation Is Associated with Schizophrenia, Major Depression, Opiate Dependence and Alcohol Dependence
por: Morris, Charles P., et al.
Publicado: (2012)

Serotonin Transporter Binding in Major Depressive Disorder: Impact of Serotonin System Anatomy
por: Bartlett, Elizabeth A, et al.
Publicado: (2022)

MAOA gene hypomethylation in panic disorder—reversibility of an epigenetic risk pattern by psychotherapy
por: Ziegler, C, et al.
Publicado: (2016)

Thermostabilization of the Human Serotonin Transporter in an Antidepressant-Bound Conformation
por: Green, Evan M., et al.
Publicado: (2015)

Multifaceted Regulations of the Serotonin Transporter: Impact on Antidepressant Response
por: Baudry, Anne, et al.
Publicado: (2019)

The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
por: Plenge, Per, et al.
Publicado: (2021)

Transcranial Magnetic Stimulation Markers of Antidepressant Treatment in Adolescents With Major Depressive Disorder
por: Doruk Camsari, Deniz, et al.
Publicado: (2019)

Meta-analysis of molecular imaging of serotonin transporters in major depression
por: Gryglewski, Gregor, et al.
Publicado: (2014)

An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report
por: Suh, Jee Su, et al.
Publicado: (2020)

Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report
por: Ballester, Pedro L., et al.
Publicado: (2021)

Commonalities and differences in the neural substrates of threat predictability in panic disorder and specific phobia
por: Klahn, Anna Luisa, et al.
Publicado: (2017)

Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression
por: James, Gregory M., et al.
Publicado: (2017)

Clinical Switching Strategies of Various Antidepressants to Vortioxetine in the PREDDICT Trial
por: Mills, Natalie T, et al.
Publicado: (2020)

Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers
por: Singh, Priyanka, et al.
Publicado: (2023)

Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder
por: Amare, Azmeraw T., et al.
Publicado: (2018)

Anti-inflammatory effects of antidepressant and atypical antipsychotic medication for the treatment of major depression and comorbid arthritis: a case report
por: Baune, Bernhard T, et al.
Publicado: (2010)

Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study
por: Baune, Bernhard T, et al.
Publicado: (2021)

Brain arousal regulation as response predictor for antidepressant therapy in major depression
por: Schmidt, Frank M., et al.
Publicado: (2017)

Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder
por: Aldosary, Fahad, et al.
Publicado: (2021)

Baseline patterns of resting functional connectivity within posterior default-mode intranetwork associated with remission to antidepressants in major depressive disorder
por: Ye, Yanxiang, et al.
Publicado: (2022)

Predictors of Electroconvulsive Therapy Outcome in Major Depressive Disorder
por: Su, Liang, et al.
Publicado: (2022)

Do the binding sites of substrates and tricyclic antidepressants overlap on the serotonin transporter?
por: Sarker, Subhodeep, et al.
Publicado: (2008)

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder
por: Martinez, James M, et al.
Publicado: (2015)

Promoter Hypomethylation of miR-124 Gene Is Associated With Major Depressive Disorder
por: Zeng, Duan, et al.
Publicado: (2021)

Alterations in serotonin transporter and body image-related cognition in anorexia nervosa
por: Yokokura, Masamichi, et al.
Publicado: (2019)

PS163. Serotonin Transporter Polymorphism in Severe Major Depressive Disorder in Indonesia
por: Arlisa, Wulandari, et al.
Publicado: (2016)

Serotonin 1A Receptor Binding of [(11)C]CUMI-101 in Bipolar Depression Quantified Using Positron Emission Tomography: Relationship to Psychopathology and Antidepressant Response
por: Lan, Martin J, et al.
Publicado: (2022)

Social Defeat Modulates T Helper Cell Percentages in Stress Susceptible and Resilient Mice
por: Ambrée, Oliver, et al.
Publicado: (2019)

Low-frequency and rare variants may contribute to elucidate the genetics of major depressive disorder
por: Yu, Chenglong, et al.
Publicado: (2018)

Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder
por: Park, Lawrence, et al.
Publicado: (2018)

Analysis of Time-Course, Dose-Effect, and Influencing Factors of Antidepressants in the Treatment of Acute Adult Patients With Major Depression
por: Cheng, Qingqing, et al.
Publicado: (2019)

Pro-Inflammatory Cytokines as Predictors of Antidepressant Effects of Exercise in Major Depressive Disorder
por: Rethorst, Chad D., et al.
Publicado: (2012)

Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma
por: Cho, M, et al.
Publicado: (2001)

Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice
por: Bowman, Melodi A., et al.
Publicado: (2020)

Rewiring of the Serotonin System in Major Depression
por: Vahid-Ansari, Faranak, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_temksihf3sjg7objjgoc8f67bg